How germline testing can guide screening and treatment options – Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center shared a post on X:

“Genetic and genomic testing can significantly impact your treatment. Dr. Carmen Calfa highlights a 42% drop in Breast Cancer mortality over 30 years. Learn how germline testing can guide screening and treatment options.”

Source: Sylvester Comprehensive Cancer Center/X

Dr. Carmen Calfa is the Medical Co-Director of the Cancer Survivorship Program at Sylvester Comprehensive Cancer Center and a Breast Medical Oncologist at Sylvester Cancer Center, UHealth. She also serves as the Associate Director of Community Outreach for the Sylvester Breast Program at Plantation, University of Miami Miller School of Medicine.